ARCHIVES

IVAX And It’s Portfolio

This article is from The Cancer Letter archive.

Vol. 20 No. 49 | December 22, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: Satcher Names CDC Director; POG Appoints Monaco To Data Monitoring Committee

September 10, 1993

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts

March 5, 1993

Cancer researchers support “responsible” human stem cell research.

July 22, 2005

Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40

April 27, 2012

June issue of Business & Regulatory Report included.

July 2, 2004